Richard Klinghoffer Ph.D. - Presage Biosciences – Comparative In Vivo Oncology

Spatial Navigator by Nanostring Technologies Inc.

Episode notes

We talk to Richard Klinghoffer Ph.D., CEO and CSO of Presage Biosciences. Presage’s Comparative In Vivo Oncology (CIVO™) system administers micro-doses of multiple drugs and/or combinations simultaneously to distinct trackable positions within a solid tumor. The tumor is then resected and analyzed to understand the microenvironment response to each spatially defined region of exposure. This is in a bid to evaluate early investigational stage cancer drugs in the most relevant context – the cancer patient, without exposing the patient to toxic effects associated with systemic delivery. We talk to Rich about his journey to Presage, the nuances between running a company and running experiments, and the field of drug development and how spatial instruments like the GeoMx DSP will influence that endeavor.

This podcast includes information reg ... 

 ...  Read more